Cite
HARVARD Citation
Tryfonidis, K. et al. (2016). A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378). European journal of cancer. pp. 144-154. [Online].